SCHEMBL12021744

SCHEMBL12021744

Cc1nc(-c2ccc(S)c(F)c2)no1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ CA12 O43570 2/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ PLK1 P53350 1/20 0.44
▸ RAB9A P51151 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TP53 P04637 2/20 0.42
▸ MAOA P21397 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ AOC3 Q16853 2/20 0.41
▸ NFKB1 P19838 2/20 0.40
▸ NFKB2 Q00653 2/20 0.40
▸ RELA Q04206 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12021892 0.87 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL14363620 0.85 L3MBTL1 (0.62) L3MBTL1CA12CA1CA2CA9
SCHEMBL7601476 0.83 L3MBTL1 (0.61) L3MBTL1CA12CA1CA2CA9
SCHEMBL25384005 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL27364860 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL8282389 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL8418331 0.80 L3MBTL1 (0.61) L3MBTL1CA12CA1CA2CA9
SCHEMBL19728838 0.79 L3MBTL1 (0.56) L3MBTL1CA12CA1CA2CA9
SCHEMBL8226427 0.79 L3MBTL1 (0.56) L3MBTL1CA12CA1CA2CA9
SCHEMBL8226165 0.77 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934227-B1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORP (US) 2011-12-21 — — EP disclosed
Send feedback